Skip to content
DefDex

Federal award

PRIMMUNE THERAPEUTICS, INC.

HDTRA124C0014

Contract

Obligated and Ceiling

Obligated (net)
$11,290,689.18
Ceiling (potential value, not spending)
$23,143,346.26
Current value
$11,290,689.18
Gross positive obligations
$11,290,689.18

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
PRIMMUNE THERAPEUTICS, INC. · RCE3KW671H83
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
PRIMMUNE THERAPEUTICS, INC. · RCE3KW671H83
Awarding agency
Department of War · sub-agency 9761 · office HDTRA1
Funding agency
Department of War · sub-agency 9761
Product or service (PSC)
AC33 · NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; EXPERIMENTAL DEVELOPMENT
Industry (NAICS)
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PIID
HDTRA124C0014
Award type code
D
Actions
15 · Jan 30, 2024 to Jun 15, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History15

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 15, 2026FY2026P00013B$79,000.00
—
Apr 20, 2026FY2026P00012C$217,508.92
—
Jan 22, 2026FY2026P00011G$366,285.39
—
Dec 12, 2025FY2026P00010B$0.00
—
Jul 25, 2025FY2025P00009M$0.00
—
May 20, 2025FY2025P00008C$1,391,142.43
—
Apr 30, 2025FY2025P00007M$0.00
—
Mar 6, 2025FY2025P00006B$0.00
—
Jan 16, 2025FY2025P00005M$0.00
—
Nov 19, 2024FY2025P00004B$1,391,142.44
—
Jul 1, 2024FY2024ARZ999M$0.00
—
May 22, 2024FY2024P00003G$5,221,301.45
—
Apr 17, 2024FY2024P00002C$1,778,698.55
—
Feb 14, 2024FY2024P00001M$0.00
—
Jan 30, 2024FY20240—$845,610.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.